Reaktionsgleichung
Cl.[C:2]12([CH2:12][CH2:13][NH2:14])[CH2:11][CH:6]3[CH2:7][CH:8]([CH2:10][CH:4]([CH2:5]3)[CH2:3]1)[CH2:9]2.[NH2:15][C:16]1[CH:24]=[CH:23][CH:22]=[C:21]([Cl:25])[C:17]=1[C:18](O)=[O:19]>>[NH2:15][C:16]1[CH:24]=[CH:23][CH:22]=[C:21]([Cl:25])[C:17]=1[C:18]([NH:14][CH2:13][CH2:12][C:2]12[CH2:9][CH:8]3[CH2:7][CH:6]([CH2:5][CH:4]([CH2:10]3)[CH2:3]1)[CH2:11]2)=[O:19]Komponenten
3
Versuchsvorschrift
Prepared according to the method of Example 14 from 1-adamantaneethylamine hydrochloride (CN 26482-53-1) (0.105 g) and 2-amino-6-chlorobenzoic acid (0.132 g) and purified by supercritical fluid chromatography eluting with CO2 in ethanol to give the title compound, contaminated with 0.35 mol equivalents of imidazole, as a white solid (0.046 g).
Aufarbeitung
- customPrepared
- custompurified by supercritical fluid chromatography
- washeluting with CO2 in ethanol
Quellen und Nachweise
- ORD-Eintrag
- ord-51bde03cf1b741c4b567555a9bcc58a0
- Quelldatensatz
- uspto-grants-2001_10
- Patentnummer
- US06303659B2
Verknüpfte Notizen
Wird geladen…